NASDAQ:UNCY

Unicycive Therapeutics Stock Company Profile

etoro logo Buy UNCY
*Your capital is at risk
$7.87
+1.02 (+14.89%)
At Close: Jun 22, 2026

Information

4300 El Camino Real, Suite 210

Los Altos CA 94022

650 351 4495

www.unicycive.com

Industry: Biotechnology

Sector: Healthcare

Unicycive Therapeutics, Inc.

Description

Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.

Click to get the best stock tips daily for free!
ABOUT UNICYCIVE THERAPEUTICS, INC.
Unicycive Therapeutics
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California....
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE